Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally


The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top